Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2871980 | The Annals of Thoracic Surgery | 2015 | 6 Pages |
Abstract
Gastrointestinal bleeding and CF-LVAD-related infections were the leading causes of readmission. Patients with a CF-LVAD spent 93% of their time out of hospital after implantation, and readmissions did not have a negative impact on long-term survival. New approaches to minimize these adverse events will continue to improve the efficacy and decrease the cost of CF-LVAD therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Shahab A. MD, Abbasali MBBS, Margaret RN, NDP, Takushi MD, PhD, Lucian MD, Satoru MD, PhD, Entela B. MD, PhD,